ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

Cefpodoxime Proxetil for Oral Suspension
Bacterial infections
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

Cefpodoxime Proxetil for Oral Suspension Rx

Generic Name and Formulations:
Cefpodoxime proxetil 50mg/5mL, 100mg/5mL; for oral susp; lemon-creme flavor.

Company:
Various generic manufacturers

Therapeutic Use:

Indications for Cefpodoxime Proxetil for Oral Suspension:

Susceptible mild to moderate infections including acute otitis media, acute bacterial exacerbations of chronic bronchitis, acute maxillary sinusitis, pharyngitis/tonsillitis, acute community-acquired pneumonia, urinary tract, skin and skin structures; cervical, anorectal (females only) and urethral gonorrhea.

Adult:

Take tabs with food. ≥13yrs: Pneumonia: 200mg every 12hrs for 14 days. Bronchitis, sinusitis: 200mg every 12hrs for 10 days. Pharyngitis/tonsillitis: 100mg every 12hrs for 5–10 days. Skin and skin structures: 400mg every 12hrs for 7–14 days. UTI: 100mg every 12hrs for 7 days. Uncomplicated gonorrhea: 200mg once as a single dose. Renal failure or hemodialysis: see full labeling.

Children:

Use susp. <2 months: not recommended. 2 months–12yrs: Acute otitis media: 5mg/kg (max 200mg) every 12hrs for 5 days. Pharyngitis/tonsillitis: 5mg/kg (max 100mg) every 12hrs for 5–10 days. Sinusitis: 5mg/kg (max 200mg) every 12hrs for 10 days.

Warnings/Precautions:

Penicillin or other allergy. Labor & delivery. Pregnancy (Cat.B). Nursing mothers: not recommended.

Interactions:

Antacids, H2 antagonists, oral anticholinergics may decrease efficacy. Potentiated by probenecid. Avoid concomitant diuretics, other nephrotoxic drugs. May cause false (+) direct Coomb's test.

See Also:

Cefpodoxime Proxetil Tablets

Pharmacological Class:

Cephalosporin.

Adverse Reactions:

GI upset, abdominal pain, headache, rash, anaphylaxis.

Note:

Formerly known under the brand name Vantin.

How Supplied:

Contact supplier.

Sign Up for Free e-Newsletters

CME Focus